Company
Headquarters: Kirrawee, NSW, Australia
CEO: Mr. Chin Leng Khoo
A$123.0 Million
AUD as of July 1, 2024
US$81.9 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Vita Life Sciences Limited, a pharmaceutical and healthcare company, develops and distributes over the counter (OTC) medicines, complementary and alternative medicines, dietary supplements, and health foods. The company offers products for nervous system, children's health, nutritional oils, immunity, hair, skin, nails, liver and digestion, nutritional's, weight management, cardiovascular health, pain, inflammation, pregnancy and breastfeeding, men and women health, antioxidant, and bones and joints. The company markets its products through pharmacies and health food stores under the Herbs of Gold, VitaHealth, VitaScience, and VitaLife brands. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, China, and internationally. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Vita Life Sciences Limited has the following listings and related stock indices.
Stock: ASX: VLS wb_incandescent